Dyne Therapeutics, Inc. (DYN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 26.00 |
| Open | 26.16 |
| Bid | 25.99 x 300 |
| Ask | 26.12 x 300 |
| Day's range | 25.87 - 27.31 |
| 52-week range | 6.40 - 30.27 |
| Volume | |
| Avg. volume | 1,262,638 |
| Market cap | 2.279B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Dyne Therapeutics Inc (DYN) Q1 2024 Earnings: Aligns with Analyst Projections
Overview of Financial Performance and Future Prospects
- GuruFocus.com
Dyne Therapeutics Inc (DYN) Reports Encouraging Clinical Data and Financial Growth for Q4 and ...
Key Clinical Trials Show Promise as Company Strengthens Financial Position
- GuruFocus.com
CEO & President Joshua Brumm Sells 100,000 Shares of Dyne Therapeutics Inc (DYN)
Joshua Brumm, CEO & President of Dyne Therapeutics Inc (NASDAQ:DYN), has sold 100,000 shares of the company on March 1, 2024, according to a recent SEC Filing.
© 2024 Yahoo. All rights reserved.